Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00527111 · ClinicalTrials.gov registry record · Phase 2
Pre-op Rectal ChemoRad +/- Cetuximab
A Phase 2 study, sponsored by US Oncology Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 139
- Enrollment target
NCT00527111: Completed Phase 2 study, sponsored by US Oncology Research.
NCT00527111 is a Phase 2 study that has completed, run by US Oncology Research. The registered enrollment target is 139 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00527111, a Phase 2 study, has completed, sponsored by US Oncology Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 139 participants
- Enrollment target
Study Summary
The purpose of this research study is to find out what effects (good and bad) cetuximab has on rectal cancer.
Primary Outcome
A pathologic complete response (pCR) is defined as no pathologic evidence of invasive disease at the primary site in the bowel wall or in examined mesorectal tissue and/or lymph nodes.
Interventions
- DRUG Cetuximab
- DRUG 5-fluorouracil
- RADIATION Pelvic irradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2007-02 |
| Est. Completion | 2015-01 |
| Phase | Phase 2 |
What the finished NCT00527111 record still lists
NCT00527111 is an interventional study that assigns participants to a tested intervention. The registered 139 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which Cetuximab is the first listed.
NCT00527111 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00527111 about?
NCT00527111 is a clinical study titled "Pre-op Rectal ChemoRad +/- Cetuximab". The purpose of this research study is to find out what effects (good and bad) cetuximab has on rectal cancer.
What is the current status of trial NCT00527111?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 139 participants. The study started on 2007-02. Estimated completion is 2015-01.
What interventions are being tested in trial NCT00527111?
The interventions under investigation include: Cetuximab (DRUG), 5-fluorouracil (DRUG), Pelvic irradiation (RADIATION).
Who is sponsoring clinical trial NCT00527111?
This trial is sponsored by US Oncology Research, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00527111's enrollment target sits among peer trials
139 525th of 2000 higher than 1,476 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05645380 · 139 participants · Phase 2
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
- NCT06239272 · 139 participants · Phase 1
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- NCT06252220 · 139 participants · Phase 1
First in Human Study in Subjects With Obesity, But Otherwise Healthy
- NCT06537128 · 139 participants · NA
Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia